Clinical Trials Logo

Methamphetamine Abuse clinical trials

View clinical trials related to Methamphetamine Abuse.

Filter by:

NCT ID: NCT00733967 Withdrawn - Substance Abuse Clinical Trials

Varenicline-Methamphetamine Interaction Study (2008)

Start date: January 2008
Phase: Phase 1
Study type: Interventional

The primary aim of the study is to determine the safety and tolerability of treatment with Varenicline in methamphetamine-dependent volunteers. The investigators also seek to determine the effects of treatment with Varenicline, as compared to placebo, on craving for methamphetamine or cigarettes following exposure to methamphetamine and smoking cues, respectively. The effects of treatment with Varenicline, as compared to placebo, on subjective effects produced by administration of methamphetamine or placebo will be attempted to be determined. Lastly, the investigators hope to determine the effects of treatment with Varenicline, as compared to placebo, on reinforcing effects produced by administration of methamphetamine or placebo.

NCT ID: NCT00603434 Completed - Clinical trials for Methamphetamine Dependence

Safety Assessment of Potential Interactions Between IV Methamphetamine and Osmotic-Release Methylphenidate (OROS-MPH)

Start date: January 2008
Phase: Phase 1
Study type: Interventional

This is a human inpatient clinical pharmacology study to assess potential interactions between intravenous (i.v.) methamphetamine infusion and oral osmotic release methylphenidate (OROS-MPH). The primary objective of this study is to determine the safety of the OROS-MPH concurrent with i.v. d-methamphetamine infusions of 15 mg and 30 mg. Safety outcome measures include cardiovascular responses [heart rate (HR), blood pressure (BP), and electrocardiograph (ECG) measurements], oral temperature, adverse events (AEs), and clinical laboratory analyses.

NCT ID: NCT00291512 Completed - HIV Infections Clinical Trials

Promoting Safer Sex in HIV+ Homosexual and Bisexual Men Who Use Methamphetamine

Start date: n/a
Phase: Phase 2
Study type: Interventional

This project studies the effectiveness of a sexual risk reduction intervention among HIV+ Men who have Sex with Men (MSM) and who use methamphetamine.